Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cholestech gets Mexican screening deal:

This article was originally published in Clinica

Executive Summary

California firm Cholestech has won a contract from the Mexican government to conduct cholesterol screening of all workers that operate public transport. The agreement is to supply the communications and transport ministry with the Cholestech LDX system - initially 42 units. This will be done through the company's Mexico City-based distributor, Nutritional Science and Technology (NST). The Mexican government decided on the LDX after the success of a six-month pilot. The system can test at point-of-care for cholesterol, blood glucose, liver enzymes, ALT and AST, and high-sensitivity C-reactive protein. Mexico performs comprehensive healthcare screening of more than 100,000 transport workers per year. The Hayward, California company says it is in discussions with other government departments to expand the programme.

You may also be interested in...



Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052002

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel